Oxidatively modified proteins as plasma biomarkers in breast cancer

Cancer Biomarkers

Volumn 13, Issue 3, 2013, Pages 193-200

  Jin, Hongjun ^a,b   Daly, Don S ^a   Marks, Jeffrey R ^c   Zangar, Richard C ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

biomarkers; Breast cancer; glutathione; hydroxynonenal; plasma; protein adducts; reactive oxygen species

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ALBUMIN; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BIOLOGICAL MARKER; CA 15-3 ANTIGEN; CD14 ANTIGEN; CERULOPLASMIN; CLUSTERIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GELATINASE A; GELATINASE B; GLUTATHIONE; INTERLEUKIN 18; INTERSTITIAL COLLAGENASE; LACTOFERRIN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR A; RANTES; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKER; VASCULOTROPIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER PATIENT; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

BLOOD PROTEINS; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84881393236     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130349     Document Type: Article

References (31)

1. World Health Organization. Fact Sheet. 2008. http://www. who.int/mediacentre/factsheets/fs297/en/.
2. R. Siegel, D. Naishadham, and A. Jemal. Cancer statistics, 2012. CA Cancer J Clin 62 (2012); 10-29.
3. C.B. Ambrosone. Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2 (2000); 903-917. (Pubitemid 32062336)
4. H. Jin and R.C. Zangar. Protein modifications as potential biomarkers in breast cancer. Biomark Insights 4 (2009); 191- 200.
5. P. Karihtala, R. Winqvist, J.E. Syvaoja, V.L. Kinnula, and Y. Soini. Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis. Eur J Cancer 42 (2006); 2653-2659. (Pubitemid 44442956)
6. J. Marx. Cancer research. Inflammation and cancer: the link grows stronger. Science 306 (2004); 966-968. (Pubitemid 39482883)
7. W.S.Wu. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25 (2006); 695-705.
8. R.C. Zangar, N. Bollinger, T.J. Weber, R.M. Tan, L.M. Markillie, and N.J. Karin. Reactive oxygen species alter autocrine and paracrine signaling. Free Radic Biol Med 51 (2011); 2041-2047.
9. Y. Zhang, R.M. Gonzalez, and R.C. Zangar. Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression. BMC Cancer 11 (2011); 69.
10. D.S. Daly, K.K. Anderson, S.L. Seurynck-Servoss, R.M. Gonzalez, A.M. White, and R.C. Zangar. An internal calibration method for protein-array studies. Stat Appl Genet Mol Biol 9 (2010); Article.
11. R.C. Zangar, D.S. Daly, A.M.White, S.L. Servoss, R.M. Tan, and J.R. Collett. ProMAT calibrator: A tool for reducing experimental bias in antibody microarrays. J Proteome Res 8 (2009); 3937-3943.
12. H. Jin, B.J. Webb-Robertson, H. Petersen, R.M. Tan, D. Bigelow, M.B. Scholand, J.R. Hoidal, J.G. Pounds, and R.C. Zangar. Smoking, COPD and nitrotyrosine levels of plasma proteins. Environ Health Perspect 119 (2011); 1314-1320.
13. H. Jin and R.C. Zangar. High-throughput, multiplexed analysis of 3-nitrotyrosine in individual proteins. Curr Protoc Toxicol Chapter 17 (2012).
14. R.M. Gonzalez, S.L. Seurynck-Servoss, S.A. Crowley, M. Brown, G.S. Omenn, D.F. Hayes, and R.C. Zangar. Development and validation of sandwich ELISA microarrays with minimal assay interference. J Proteome Res 7 (2008); 2406- 2414.
15. R.L. Woodbury, S.M. Varnum, and R.C. Zangar. Elevated HGF levels in sera from breast cancer patients detected using a protein microarray ELISA. 2003/03/21 (2002); 233-237. (Pubitemid 36050253)
16. A.M. White, D.S. Daly, S.M. Varnum, K.K. Anderson, N. Bollinger, and R.C. Zangar. ProMAT: protein microarray analysis tool. 2006/04/06 (2006); 1278-1279.
17. L.E. Moses, D. Shapiro, and B. Littenberg. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12 (1993); 1293-1316. (Pubitemid 23230833)
18. R Development Team. A language and environment for statistical computing. In: R Foundation for Statistical Computing, editor. 2010.
19. W.N. Venables, and B.D. Ripley. Modern Applied Statistics with S. 4th ed. Springer; 2002.
20. T. Sing, O. Sander, N. Beerenwinkel, and T. Lengauer. ROCR: visualizing classifier performance in R. Bioinformatics 21 (2005); 3940-3941. (Pubitemid 41535515)
21. S.M. Varnum, C.C. Covington, R.L. Woodbury, K. Petritis, L.J. Kangas, M.S. Abdullah, J.G. Pounds, R.D. Smith, and R.C. Zangar. Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer. Breast Cancer Research and Treatment 80 (2003); 87-97. (Pubitemid 36851288)
22. W.N. Chen, R.L. Woodbury, L.E. Kathmann, L.K. Opresko, R.C. Zangar, H.S. Wiley, and B.D. Thrall. Induced autocrine signaling through the epidermal growth factor receptor contributes to the response of mammary epithelial cells to tumor necrosis factor alpha. J Biol Chem 279 (4-30-2004); 18488- 18496.
23. K.D. Rodland, N. Bollinger, D. Ippolito, L.K. Opresko, R.J. Coffey, R. Zangar, and H.S. Wiley. Multiple mechanisms are responsible for transactivation of the epidermal growth factor receptor in mammary epithelial cells. J Biol Chem 283 (2008); 31477-31487.
24. M. Maemura, Y. Iino, T. Yokoe, J. Horiguchi, H. Takei, Y. Koibuchi, Y. Horii, I. Takeyoshi, S. Ohwada, and Y.Morishita. Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer. Cancer Lett 126 (4-24-1998); 215-220.
25. D.R. Gough, and T.G. Cotter. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis 2 (2011); e213.
26. H. Antelmann, and J.D. Helmann. Thiol-based redox switches and gene regulation. Antioxid Redox Signal 14 (3-15-2011); 1049-1063.
27. P. Karihtala, S. Kauppila, U. Puistola, and A. Jukkola-Vuorinen. Divergent behaviour of oxidative stress markers 8- hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis. Histopathology 58 (2011); 854-862.
28. W. Wu, M.K. Samoszuk, S.A. Comhair, M.J. Thomassen, C.F. Farver, R.A. Dweik, M.S. Kavuru, S.C. Erzurum, and S.L. Hazen. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 105 (2000); 1455- 1463. (Pubitemid 30322411)
29. P. Karihtala, V.L. Kinnula, and Y. Soini. Antioxidative response for nitric oxide production in breast carcinoma. Oncol Rep 12 (2004); 755-759.
30. M. Samoszu, M.L. Brennan, V. To, L. Leonor, L. Zheng, X. Fu, and S.L. Hazen. Association between nitrotyrosine levels and microvascular density in human breast cancer. Breast Cancer Res Treat 74 (2002); 271-278. (Pubitemid 34848354)
31. R.M. Gonzalez, D.S. Daly, R. Tan, J.R. Marks, and R.C. Zangar. Plasma biomarkers profiles differ depending on breast cancer subtype but RANTES is consistently increased. Cancer Epidemiol Biomarkers Prev 20 (2011); 1543-1551.